Patient Guide: A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 46 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05342636
Status: COMPLETED
Condition: Esophageal Squamous Cell Carcinoma (ESCC)
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 46 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Natal, Rio Grande do Norte
  • • Porto Alegre, Rio Grande do Sul
  • • São Paulo, São Paulo
  • • And 43 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) - Join Clinical Trial NCTNCT05342636

How to Join This Clinical Trial - NCTNCT05342636

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Esophageal Squamous Cell Carcinoma (ESCC). Current status: COMPLETED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Esophageal Squamous Cell Carcinoma (ESCC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Esophageal Squamous Cell Carcinoma (ESCC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
COMPLETED
Study Identifier
NCTNCT05342636 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 46 locations. Find a study site near you:

Clinical Research Site

Natal, Rio Grande do Norte 59062-000 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande do Sul 91350-200 - Brazil

Status: Contact for availability

Clinical Research Site

São Paulo, São Paulo 01246-000 - Brazil

Status: Contact for availability

Clinical Research Site

Santiago, Region M. de Santiago 7500921 - Chile

Status: Contact for availability

Clinical Research Site

Santiago, Region M. de Santiago 7591047 - Chile

Status: Contact for availability

Clinical Research Site

Brest, Finistere 29200 - France

Status: Contact for availability

Clinical Research Site

Lille, Nord 59037 - France

Status: Contact for availability

Clinical Research Site

Paris, Orne 75013 - France

Status: Contact for availability

Clinical Research Site

Frankfurt am Main, Hesse 60488 - Germany

Status: Contact for availability

Clinical Research Site

Düsseldorf, North Rhine-Westphalia 40225 - Germany

Status: Contact for availability

And 36 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Esophageal Squamous Cell Carcinoma (ESCC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation